Page last updated: 2024-10-31

mitoxantrone and Plasma Cell Tumor

mitoxantrone has been researched along with Plasma Cell Tumor in 2 studies

Mitoxantrone: An anthracenedione-derived antineoplastic agent.
mitoxantrone : A dihydroxyanthraquinone that is 1,4-dihydroxy-9,10-anthraquinone which is substituted by 6-hydroxy-1,4-diazahexyl groups at positions 5 and 8.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19901 (50.00)18.7374
1990's0 (0.00)18.2507
2000's1 (50.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Engel, R1
Valkov, NI1
Gump, JL1
Hazlehurst, L1
Dalton, WS1
Sullivan, DM1
Wang, BS1
Ruszala-Mallon, V1
Wallace, RE1
Citarella, RV1
Lin, YI1
Durr, FE1

Other Studies

2 other studies available for mitoxantrone and Plasma Cell Tumor

ArticleYear
The cytoplasmic trafficking of DNA topoisomerase IIalpha correlates with etoposide resistance in human myeloma cells.
    Experimental cell research, 2004, May-01, Volume: 295, Issue:2

    Topics: Antibiotics, Antineoplastic; Antineoplastic Agents; Antineoplastic Agents, Phytogenic; Blotting, Wes

2004
Modulation of the immune response to tumors by a novel synthetic compound, N-[4-[(4-fluorophenyl)sulfonyl]phenyl] acetamide (CL 259,763).
    Cancer immunology, immunotherapy : CII, 1986, Volume: 22, Issue:1

    Topics: Adjuvants, Immunologic; Animals; Anthraquinones; Antineoplastic Agents; Cell Line; Colony-Stimulatin

1986